Pierce Group Ab buy krebskrebs
Start price
21.03.22
/
50%
€2.78
Target price
21.03.23
€3.20
Performance (%)
-73.99%
End price
22.03.23
€0.72
Summary
This prediction ended on 22.03.23 with a price of €0.72. Massive losses of -73.99% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pierce Group Ab | - | - | - |
iShares Core DAX® | 2.749% | 4.620% | 17.121% |
iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% |
iShares Nikkei 225® | -2.930% | -5.556% | 12.185% |
iShares S&P 500 | 0.679% | 0.631% | 28.996% |
Comments by krebskrebs for this prediction
In the thread Pierce Group Ab diskutieren
Buy mit Kursziel 3,2
In the thread Trading Pierce Group Ab
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten